Jasper Therapeutics JSPRW Stock
Jasper Therapeutics Price Chart
Jasper Therapeutics JSPRW Financial and Trading Overview
| Jasper Therapeutics stock price | 0.01 USD |
| Previous Close | 0.01 USD |
| Open | 0.08 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.01 - 0.01 USD |
| 52 Week Range | 0.01 - 0.01 USD |
| Volume | 14.73K USD |
| Avg. Volume | N/A |
| Market Cap | N/A |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.836 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
JSPRW Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.12066116 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Jasper Therapeutics Stock Price History
| Beta (5Y Monthly) | N/A |
| 52-Week Change | N/A |
| S&P500 52-Week Change | 27.18% |
| 52 Week High | 0.01 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | N/A |
| 200-Day Moving Average | N/A |
JSPRW Share Statistics
| Avg. Volume (3 month) | N/A |
| Avg. Daily Volume (10-Days) | N/A |
| Shares Outstanding | N/A |
| Float | 21.88M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -112.23% |
| Return on Equity (ttm) | -244.21% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -69935000 USD |
| Net Income Avi to Common (ttm) | -55734000 USD |
| Diluted EPS (ttm) | -3.836 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 14.14M USD |
| Total Cash Per Share (mrq) | 0.51 USD |
| Total Debt (mrq) | 757K USD |
| Total Debt/Equity (mrq) | 22.27 USD |
| Current Ratio (mrq) | 2.256 |
| Book Value Per Share (mrq) | 0.121 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -68867000 USD |
| Levered Free Cash Flow (ttm) | -40737124 USD |
Profile of Jasper Therapeutics
| Country | United States |
| State | CA |
| City | Redwood City |
| Address | 2200 Bridge Pkwy |
| ZIP | 94065 |
| Phone | 650 549 1400 |
| Website | https://jaspertx.com |
| Industry | |
| Sector(s) | |
| Full Time Employees | 22 |
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapeutics targeting mast stem cell driven diseases in the United States. The company's lead product candidate is briquilimab, a monoclonal antibody designed to block stem cell factors from binding to and signaling through the CD117 receptor on mast and stem cells. It focuses on the development and commercialization of therapeutic agents for patients with various mast cell driven diseases, including chronic spontaneous urticaria, chronic inducible urticaria, and asthma. Jasper Therapeutics, Inc. was founded in 2018 and is headquartered in Redwood City, California.
Q&A For Jasper Therapeutics Stock
What is a current JSPRW stock price?
Jasper Therapeutics JSPRW stock price today per share is 0.01 USD.
How to purchase Jasper Therapeutics stock?
You can buy JSPRW shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Jasper Therapeutics?
The stock symbol or ticker of Jasper Therapeutics is JSPRW.
How many shares does Jasper Therapeutics have in circulation?
The max supply of Jasper Therapeutics shares is 0.
What is Jasper Therapeutics Price to Earnings Ratio (PE Ratio)?
Jasper Therapeutics PE Ratio is now.
What was Jasper Therapeutics earnings per share over the trailing 12 months (TTM)?
Jasper Therapeutics EPS is -3.836 USD over the trailing 12 months.